Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Chemed Inc (CHE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
LHCG or CHE: Which Is the Better Value Stock Right Now?

LHCG vs. CHE: Which Stock Is the Better Value Option?

CHE : 328.24 (+0.06%)
LHCG : 74.95 (+0.19%)
Report: Developing Opportunities within El Pollo Loco, Chemed, Novo Nordisk A/S, FactSet Research, Fair Isaac, and HCP -- Future Expectations, Projections Moving into 2018

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of El Pollo Loco Holdings, Inc....

CHE : 328.24 (+0.06%)
FDS : 202.59 (+0.34%)
HCP : 23.11 (-0.43%)
NVO : 48.10 (-0.35%)
LOCO : 10.90 (+0.93%)
FICO : 181.08 (-0.43%)
Should Vanguard S&P Small-Cap 600 Growth ETF (VIOG) Be on Your Investing Radar?

Style Box ETF report for VIOG

IWO : 201.64 (+0.12%)
CHE : 328.24 (+0.06%)
FIVE : 73.19 (+0.70%)
VIOG : 159.34 (+0.05%)
ASGN : 79.74 (-3.89%)
VBK : 173.21 (+0.04%)
New Strong Buy Stocks for May 21st

New Strong Buy Stocks for May 21st

EQNR : 26.12 (-1.88%)
DLPH : 52.20 (-1.38%)
CHE : 328.24 (+0.06%)
CSIQ : 16.72 (-1.18%)
LXFR : 18.20 (+1.73%)
Here's Why You Should Invest in Illumina (ILMN) Stock Now

Illumina (ILMN) gains ground on product launches and international prospects.

CHE : 328.24 (+0.06%)
AMED : 74.00 (+0.03%)
ILMN : 270.83 (-0.33%)
ISRG : 457.79 (-0.20%)
Why Is Chemed (CHE) Up 13.6% Since Its Last Earnings Report?

Chemed (CHE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

CHE : 328.24 (+0.06%)
Amedisys or Chemed: Which is a Better Investment Choice?

After considering various parameters and fundamentals, we help you make a choice between Amedisys (AMED) and Chemed (CHE).

CHE : 328.24 (+0.06%)
LHCG : 74.95 (+0.19%)
AMED : 74.00 (+0.03%)
EVHC : 43.21 (+0.28%)
CryoLife (CRY) Stock Gains 9.5% on Impressive Q1 Earnings

CryoLife's (CRY) shares gain on growth in all product lines along with strong performance in all geographies in Q1.

CHE : 328.24 (+0.06%)
BAX : 72.41 (+0.08%)
CRY : 26.95 (+0.75%)
ISRG : 457.79 (-0.20%)
Orthofix (OFIX) Stock Declines 13% on '18 Earnings View Cut

Despite the bottom line of Orthofix (OFIX) betters estimates, the company's shares drop due to trimmed 2018 earnings outlook.

CHE : 328.24 (+0.06%)
OFIX : 54.49 (+0.18%)
BAX : 72.41 (+0.08%)
ISRG : 457.79 (-0.20%)
Chemed (CHE) Stock is Worth a Bet Right Now: Here's Why

Chemed (CHE) sees a stellar Q1 backed by steady year-over-year revenue growth in both of its subsidiaries.

CHE : 328.24 (+0.06%)
BAX : 72.41 (+0.08%)
ALGN : 317.04 (+2.87%)
ISRG : 457.79 (-0.20%)
Uptrend Call Working As Chemed Corp Stock Rises 23.3% (CHE)

SmarTrend identified an Uptrend for Chemed Corp (NYSE:CHE) on March 5th, 2018 at $264.77. In approximately 2 months, Chemed Corp has returned 23.32% as of today's recent price of $326.50.

CHE : 328.24 (+0.06%)
BioScrip (BIOS) Q1 Loss Wider Than Expected, Revenues Beat

BioScrip's (BIOS) shift in strategy to raise core revenue mix hampers growth in Q1. Year-over-year rise in core product mix buoys optimism.

CHE : 328.24 (+0.06%)
BIOS : 2.51 (unch)
BAX : 72.41 (+0.08%)
ISRG : 457.79 (-0.20%)
STERIS (STE) Q4 Earnings & Revenues Beat Estimates, Up Y/Y

Favorable underlying market trends along with a slew of new product and service offerings by STERIS (STE) instill confidence in investors.

CHE : 328.24 (+0.06%)
STE : 104.49 (-0.18%)
BAX : 72.41 (+0.08%)
ISRG : 457.79 (-0.20%)
Wright Medical (WMGI) Beats on Q1 Earnings, Keeps Guidance

Wright Medical's (WMGI) Q1 results solid; growth in upper and lower extremities segments encourages.

WMGI : 24.83 (+0.36%)
CHE : 328.24 (+0.06%)
BAX : 72.41 (+0.08%)
ISRG : 457.79 (-0.20%)
Haemonetics (HAE) Q4 Earnings Meet, Revenues Beat Estimates

Continued generation of new business and geographical expansion drive Haemonetics' (HAE) Q4 results.

CHE : 328.24 (+0.06%)
BAX : 72.41 (+0.08%)
ISRG : 457.79 (-0.20%)
HAE : 90.38 (-0.43%)
Penumbra (PEN) Q1 Earnings & Revenues Top Estimates, View Up

Penumbra (PEN) benefits from strong growth across all geographies and product lines in Q1.

CHE : 328.24 (+0.06%)
PEN : 156.00 (-0.22%)
BAX : 72.41 (+0.08%)
ISRG : 457.79 (-0.20%)
Luminex (LMNX) Beats Q1 Estimates on ARIES Platform Strength

Luminex (LMNX) gains on ARIES and VERIGENE platforms in Q1; a solid guidance encourages.

CHE : 328.24 (+0.06%)
LMNX : 27.57 (-0.29%)
BAX : 72.41 (+0.08%)
ISRG : 457.79 (-0.20%)
Myriad Genetics (MYGN) Beats on Earnings & Revenues in Q3

Myriad Genetics' (MYGN) Q3 revenues decline year over year. Strong demand for GeneSight, Vectra DA and Prolaris tests was encouraging.

CHE : 328.24 (+0.06%)
MYGN : 35.94 (+1.27%)
BAX : 72.41 (+0.08%)
ISRG : 457.79 (-0.20%)
Henry Schein's (HSIC) Q1 Earnings Beat, '18 View Intact

We currently await the completion of Henry Schein's (HSIC) planned spin-off of global Animal Health business. This business contributes nearly 30% to the company's top line.

CHE : 328.24 (+0.06%)
HSIC : 70.51 (-0.16%)
BAX : 72.41 (+0.08%)
ISRG : 457.79 (-0.20%)
Amedisys (AMED) Q1 Earnings, Revenues Beat on Overall Growth

Robust growth in Medicare and non-Medicare revenues at Amedisys' (AMED) Home Health and Hospice divisions boost the company's Q1 results.

CHE : 328.24 (+0.06%)
AMED : 74.00 (+0.03%)
BAX : 72.41 (+0.08%)
ISRG : 457.79 (-0.20%)

Van Meerten Stock Picks

5 Great Growth Stocks
This morning I wanted to find 5 stocks that were predicted to have double digit growth in both Revenue and Earnings over the next 5 years that were also having great current performance.
LULU +1.14 , ABMD -1.06 , AAXN +2.28 , NSP +0.90 , ERI +1.00
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.
Free Commodities Newsletter

Get prepared for your trading day with

Barchart's Commodity Futures Morning Update Email

InsideFutures Commentary

InsideFutures weekly newsletter features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Friday morning to your inbox.

Brugler Ag Report

Today's Commentary

Corn futures were weak into the close on Thursday, down 3 to 4 1/4 cents lower in the front months. Traders were taking money off the table ahead of the extended weekend. The USDA reported a private cancelation of 132,000 of grain sorghum to unknown ...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar